deltatrials

Stage iiic breast cancer Trials in Columbus, United States

Conditions / Stage iiic breast cancer / Columbus, United States

Stage iiic breast cancer has been the subject of sustained clinical investigation across multiple research sites.

11 total trials for this combination

Showing top 10 of 11 trials

Trials

NCT ID Title Status Phase
NCT02203552 Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer COMPLETED PHASE2
NCT02400060 Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer COMPLETED NA
NCT01953588 Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery ACTIVE_NOT_RECRUITING PHASE3
NCT02488967 Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer ACTIVE_NOT_RECRUITING PHASE3
NCT01478477 Omega-3 Fatty Acids in Preventing Joint Symptoms in Patients With Stage I-III Breast Cancer Receiving Anastrozole, Exemestane, or Letrozole COMPLETED NA
NCT02728596 S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) COMPLETED NA
NCT03039140 Cardiac Rehabilitation Program in Improving Cardiorespiratory Fitness in Stage 0-III Breast Cancer Survivors COMPLETED NA
NCT02760030 Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery COMPLETED PHASE2
NCT01238133 Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer TERMINATED PHASE1
NCT02445391 Platinum in Treating Patients With Residual Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy ACTIVE_NOT_RECRUITING PHASE3

Related Pages